Bioequivalence and Bioavailability Clinical Trials: A Status Report from the National Institutes of Health ClinicalTrials.gov Registry

Drug development is an expensive process that is marked by a high-failure rate. For this reason early stage bioequivalence and pharmacokinetic studies are essential in determining the fate of new drug products. In this study, we sought to systematically assess the current trends of ongoing and recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockmann, Chris, Spigarelli, Michael G, Ampofo, Krow, Sherwin, Catherine MT
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201122/
https://www.ncbi.nlm.nih.gov/pubmed/25328346
http://dx.doi.org/10.4172/jbb.1000167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201122/
https://www.ncbi.nlm.nih.gov/pubmed/25328346
http://dx.doi.org/10.4172/jbb.1000167

Ejemplares similares